Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of the COVID-19 Pandemic on the Reporting and Management of Multiple Sclerosis Relapses

NCT04858763 is registered in ClinicalTrials.gov with Nottingham University Hospitals NHS Trust as lead sponsor.

NCT NCT04858763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04858763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of the COVID-19 Pandemic on the Reporting and Management of Multiple Sclerosis Relapses
Lead sponsor
Nottingham University Hospitals NHS Trust
Phase
Observational
Overall status
Completed
Start date
July 1, 2021
Completion date
June 20, 2023
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, multiple sclerosis, relapsing remitting multiple sclerosis